← Leaderboards
Alon Harris
Indiana University Indianapolis
$1,562,726
Attributed
$2,706,202
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $613.9K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,706,202 · 3
By mechanism
R01$2,286,952 · 2
R21$419,250 · 1
Top collaborators
- Julia Arciero4 shared
- Giovanna Guidoboni4 shared
Others in their field
Top investigators on “Hemodynamics”
- Alan Jasanoff · Massachusetts Institute Of Technology$22,516,687
- Jay D Humphrey · Yale University$22,350,674
- Angela L. Jefferson · Vanderbilt University Medical Center$21,651,697
- Robert Freedman · University Of Colorado Denver$20,038,696
- Danny Bluestein · State University New York Stony Brook$18,226,851
- Kent A Kiehl · Hartford Hospital$17,001,778
Research focus
HemodynamicsMeasurementRetinaStructureBlood FlowGlaucomaBlood VesselsMathematicsDiagnosisCollectionData SetClinical DataBlindnessInnovationThickVisionPressureVisual FieldsDesignBlood CapillariesMicrocirculationIndexingOptic NerveBlood Pressure
Grant awards (10)
SCH: SEEthroughGLAUCOMA: Smart Eye Emulator (SEE) to study glaucoma risk factors$217,817
R01 · FY2025 · EY
SCH: SEEthroughGLAUCOMA: Smart Eye Emulator (SEE) to study glaucoma risk factors$225,049
R01 · FY2024 · EY
Integration of clinical measures and theoretical modeling to quantify sectorial specific changes in ocular structure, function, and hemodynamics$323,538
R01 · FY2023 · EY · contact PI
SCH: SEEthroughGLAUCOMA: Smart Eye Emulator (SEE) to study glaucoma risk factors$232,608
R01 · FY2023 · EY
Integration of clinical measures and theoretical modeling to quantify sectorial specific changes in ocular structure, function, and hemodynamics$313,852
R01 · FY2022 · EY · contact PI
SCH: SEEthroughGLAUCOMA: Smart Eye Emulator (SEE) to study glaucoma risk factors$300,000
R01 · FY2022 · EY
Integration of clinical measures and theoretical modeling to quantify sectorial specific changes in ocular structure, function, and hemodynamics$314,169
R01 · FY2021 · EY · contact PI
Integration of clinical measures and theoretical modeling to quantify sectorial specific changes in ocular structure, function, and hemodynamics$359,919
R01 · FY2020 · EY · contact PI
African and European Descent, Ocular Blood Flow and Glaucoma Progression$185,250
R21 · FY2013 · EY · contact PI
African and European Descent, Ocular Blood Flow and Glaucoma Progression$234,000
R21 · FY2012 · EY · contact PI